What Bioscience Institute does

Bioscience Institute S.p.A. is a privately held regenerative medicine and genomics company founded in 2006 and headquartered in Falciano, San Marino, operating across Europe, the Middle East, and North America. It runs a vertically integrated portfolio built on mesenchymal stem cell (MSC) and ADMSC-exosome science, spanning elective aesthetic procedures (SKILLSKILL, BREASTSKILL, HAIRSKILL, GYNSKILL, MALESKILL), clinical regenerative treatments (ORTHOSKILL, OVOSKILL, ANDROSKILL, XEROSKILL, ENSKILL, CARESKILL), and a corresponding exosome therapy line (EXOSKIN, EXOHAIR, EXOJOINTS, EXOMALE, EXOFEMALE, EXOSPORT, EXOAGEING). Complementing the therapeutic offer, the company delivers molecular diagnostics and screening — the ULTRANIPT non-invasive prenatal test validated on 112,669 pregnancies, the OMNIPT WIDE expanded panel, MYCARRIER carrier screening (>1,200 genes), G-TEST, NEONATEST and NEONASEQ neonatal screening, HELIXPAN genomic instability monitoring via NGS, and the HELIXAFE Cancer Driver Interception and BIOXPACE Longevity protocols. Stem cell banking (cord blood, cord tissue, adipose-derived MSC) provides recurring, biologically locked-in storage relationships, while the branded NGTX nutraceutical line (CYTOXAFE, BIOXAFE, GENEXAFE, MYCROGENOX) and ADMSC-exosome cosmetics (X-FILL, X-LIFT, X-SKIN, X-HAIR) extend the portfolio into packaged consumer products.

Revenue is generated through six streams: high-margin professional services for MSC and exosome clinical procedures; genetic and prenatal testing on a fee-for-service basis; subscription/recurring stem cell banking; unit-priced nutraceutical and topical exosome cosmetics sold via the shop.bioinst.com storefront; and subscription preventive programs (HELIXAFE, BIOXPACE) combining diagnostics with supplements. The company delivers services through owned facilities — San Marino headquarters and cryobank (clean rooms Class A-B and C, biological nitrogen storage), two Dubai Healthcare City clinics (primary aesthetic/regenerative hub and Bioscience Clinic UAE), the Bioscience Genomics laboratory at Università degli Studi di Roma Tor Vergata, and Bioscience Institute Inc. at Harvard Medical School Life Lab in Boston — alongside a direct-to-consumer website with an online shop, multilingual interface (English, Italian, Arabic, Chinese), and partnership programs for healthcare professionals, clinics, and medical centers that offer training, certification, and ongoing scientific support to deliver regenerative protocols under the Bioscience banner. The customer base segments into four primary verticals: aesthetic and cosmetic patients, clinical/regenerative medicine patients with degenerative or chronic conditions, prenatal/reproductive health families, and longevity- and prevention-focused individuals, with healthcare professionals serving as a B2B channel rather than a primary end market. Governance is led by CEO Giuseppe Mucci; no external funding rounds, parent company, acquisitions, or regulatory enforcement actions were disclosed in the source material.

Name

Bioscience Institute

Legal name

Bioscience Institute S.p.A.

Website

https://bioinst.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

51–100 employees

Short description

Bioscience Institute is a private regenerative medicine and genomics company operating clinical and laboratory facilities in San Marino, Dubai, Rome, and Boston. It delivers MSC and exosome therapies, non-invasive prenatal screening, cancer interception and longevity protocols, stem cell banking, and a branded nutraceutical line to affluent individual consumers.

Ownership category

akta.pro rank

Product category

Regenerative Medicine

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Stem Cell–Based Regenerative Therapies (HLAAAGAA)

akta.pro secondary industries

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

Keywords

• Regenerative medicine services
• Stem cell banking
• Prenatal genetic screening
• Cancer interception diagnostics
• Longevity biomarker testing

Headquarters

HQ city

Falciano

HQ country

San Marino

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Stem Cell Treatments: Regenerative medicine procedures using Mesenchymal Stem Cells and exosome therapy for aesthetic, clinical, and functional applications including skin rejuvenation, hair loss, orthopedics, and anti-aging IV therapies.
2. Genetic and Prenatal Testing: Non-invasive prenatal testing (ULTRANIPT, G-TEST), carrier screening (MYCARRIER), neonatal screening, and genomic cancer testing services.
3. Stem Cell Banking: Cryopreservation services for cord blood, cord tissue, and adipose-derived mesenchymal stem cells for future autologous therapies.
4. Nutraceuticals and Food Supplements: NGTX advanced food supplements (CYTOXAFE, BIOXAFE, GENEXAFE, MYCROGENOX) and preventive support supplements (CYTODRIVE, MICRODRIVE, HELIXDRIVE, IMMUNEDRIVE) sold through online shop.
5. Exosome Cosmetics: Topical cosmetic products containing ADMSC exosomes including X-FILL (eye/lip contour), X-LIFT (facial lifting), X-SKIN (moisturizing), and X-HAIR (hair loss).
6. Cancer Prevention Programs: HELIXAFE cancer driver interception protocol and BIOXPACE longevity protocols providing comprehensive monitoring and intervention programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Bioscience Institute delivers regenerative medicine services, proprietary molecular diagnostic and prevention programs, and related consumer products. Its clinical core is autologous mesenchymal stem cell (MSC) and MSC-exosome therapy delivered across aesthetic, orthopedic, and chronic-care indications, complemented by stem cell banking (cord blood, cord tissue, adipose-derived MSCs). Molecular diagnostics include the non-invasive prenatal screen ULTRANIPT (validated on 112,669 pregnancies), the HELIXAFE cancer driver interception platform, and the BIOXPACE longevity biomarker protocol. The portfolio is rounded out by genotoxicity-free NGTX nutraceuticals, preventive supplements, and exosome-based cosmetics.

Product overview

Bioscience Institute operates as a multi-platform healthcare company offering four integrated product lines: CELLSKILL (stem cells and exosomes for regenerative medicine), HELIXAFE (cancer driver interception and prevention), BIOXPACE (longevity and healthy aging protocols), and ULTRANIPT (prenatal and neonatal genetic screening). The portfolio also includes comprehensive stem cell banking services (cord blood, cord tissue, and adipose-derived), exosome treatments for aesthetic and therapeutic applications, extensive food supplement lines including the genotoxicity-free NGTX series, and exosome-based cosmetics. The company provides laboratory services across multiple international locations in Europe, Middle East, and United States.

Differentiator

Problem solved

Functional benefit

Brands

• BIOXPACE: Personalized longevity platform integrating molecular analysis, biomarker monitoring, and tailored interventions for healthy aging.
• HELIXAFE
• CELLSKILL
• ULTRANIPT
• NGTX

Products and services

• BIOXPACE - Healthy Longevity Program Integrated molecular longevity protocol that provides a personalized biological map of aging using biomarkers covering inflammation, cellular senescence, DNA damage, immune function, gut microbiome, and nano/microplastic load, and that guides prevention strategies, functional optimization, and therapeutic interventions for health-conscious individuals.
• HELIXAFE - Cancer Driver Interception Prevention model that analyses molecular and genomic factors underlying carcinogenesis through comprehensive profiling of inflammatory pathways (CYTOBALANCE), microbiome composition (MICROBALANCE), genomic stability (HELIXBALANCE), and immune regulation (IMMUNEBALANCE), aimed at individuals seeking cancer risk interception.
• CELLSKILL - Stem Cells and Exosome Treatments Integrated portfolio of regenerative solutions based on autologous Mesenchymal Stem Cells (MSCs) and MSC-derived exosomes, covering aesthetic applications (skin rejuvenation, breast augmentation, hair loss, intimate wellness), clinical applications (orthopedics, premature ovarian failure, erectile dysfunction, anti-aging IV therapy), and supportive care for chronic conditions (xerostomia, empty nose syndrome, COPD, MS, liver cirrhosis, Crohn's disease).
• ULTRANIPT - Prenatal and Neonatal Screening Most comprehensive non-invasive prenatal screening, validated on 112,669 pregnancies (largest clinical study worldwide), detecting chromosomal abnormalities, microdeletions, and monogenic disorders using cell-free fetal DNA and state-of-the-art genomic technologies; complemented by neonatal screening (NEONATEST, NEONASEQ) and carrier screening (MYCARRIER) for expectant parents and newborns.
• LIPOSKILL SAVE - Adipose-Derived Stem Cell Banking Cryopreservation service that stores adipose-derived mesenchymal stem cells (ADMSCs) from a patient's fat tissue in the San Marino cryobank, preserving MSCs for future autologous therapies such as aesthetic and regenerative treatments. Available at any age.
• CORD BLOOD SAVE - Cord Blood Stem Cell Banking Preservation of cord blood hematopoietic stem cells for potential treatment of leukemias, lymphomas, bone marrow failure syndromes, and other blood disorders, with over 40,000 cord blood stem cell transplants reported worldwide treating more than 80 diseases.
• CORD TISSUE SAVE - Cord Tissue Stem Cell Banking Preservation of mesenchymal stem cells from Wharton's jelly in umbilical cord tissue, retaining anti-inflammatory and tissue regeneration properties for future autologous or family therapeutic use.
• G-TEST - Non-Invasive Prenatal Test Non-invasive prenatal test analyzing fetal DNA from week 10 of pregnancy with >99% sensitivity for main trisomies, intended for expectant parents seeking early chromosomal screening.
• MYCARRIER - Expanded Carrier Screening Expanded preconception and prenatal carrier screening using next-generation sequencing (NGS) to detect mutations in more than 1,200 genes associated with over 1,200 genetic diseases, for couples planning pregnancy.
• NEONATEST - Expanded Neonatal Screening Expanded neonatal screening using tandem mass spectrometry to detect inherited metabolic diseases in the first days of life, for newborns whose parents opt into extended metabolic screening beyond standard panels.
• SKINSKILL - Skin Rejuvenation Stem Cell Treatment Advanced skin rejuvenation therapy using autologous MSC transplantation to replace damaged fibroblasts and keratinocytes and to stimulate collagen and elastin production, for patients seeking regenerative skin treatments without surgery.
• BREASTSKILL - Natural Breast Augmentation Natural breast augmentation using autologous fat enriched with expanded MSCs, delivering 80–90% volume retention via MSC-enhanced vascularization without synthetic implants, for patients seeking natural-looking breast enhancement.
• ORTHOSKILL - Osteoarticular Regeneration MSC therapy that leverages differentiation of mesenchymal stem cells into chondrocytes, osteoblasts, and tenocytes to repair musculoskeletal tissue, for patients with osteoarticular degeneration.
• AGESKILL - Anti-Aging IV Therapy Systemic anti-aging IV therapy that delivers MSCs intravenously for body-wide tissue regeneration and anti-aging benefits, for patients seeking whole-body regenerative interventions.
• CYTOXAFE NGTX Food Supplement Genotoxicity-free NGTX advanced food supplement (40 capsules per box) for cellular protection and oxidative stress containment, containing Haematococcus pluvialis astaxanthin, holy basil, selenium, curcumin, and lycopene; sold through the online shop to support preventive cancer and longevity protocols.
• BIOXAFE NGTX Food Supplement Genotoxicity-free NGTX advanced food supplement (60 capsules per box) for immune support and systemic resilience, containing echinacea, spirulina, resveratrol, sprouted wheat (spermidine), zinc, and vitamin D3; sold through the online shop.
• GENEXAFE NGTX Food Supplement Genotoxicity-free NGTX advanced food supplement (40 tablets per box) supporting cellular function and energy metabolism, containing chlorella, B vitamins from buckwheat, NADH, and vitamin D; sold through the online shop.
• MYCROGENOX NGTX Food Supplement Genotoxicity-free NGTX advanced food supplement (40 capsules per box) supporting the gut-liver-microbiota axis, containing berberine, ginger, milk thistle, and tyndallized lactobacilli (L. casei, L. acidophilus, L. plantarum) at 25 billion non-viable cells; sold through the online shop.
• IMMUNEDRIVE - Immune Support Supplement Preventive food supplement (€22 per box of 30 capsules) for immune system support and inflammation control, containing Vitamin C, Vitamin D, Acerola, Withania, and enzymatic complexes, marketed as part of the preventive cancer therapy line.
• HELIXDRIVE - Oxidative Stress Protection Supplement Preventive food supplement (€32 per box) for DNA protection from oxidative stress, containing Vitamin E and Resveratrol, marketed as part of the genomic-instability prevention line.
• X-HAIR - Exosome Cosmetics for Hair Loss Topical exosome-based cosmetic product for hair loss treatment, containing adipose-derived mesenchymal stem cell (ADMSC) exosomes with Malus Domestica fruit cell culture extract, caffeine, adenosine, and other active ingredients to promote hair growth; sold through the online shop.
• X-FILL - Eye and Lip Contour Serum Exosome-based 3D serum for eye and lip contour treatment, containing MSC-derived exosomes for targeted skin application; sold through the online shop as an adjunct to clinical regenerative aesthetic programs.
• X-LIFT - Firm Facial Lifting Serum Exosome-based 3D serum for firm facial lifting and skin tightening, containing MSC-derived exosomes; sold through the online shop.
• X-SKIN - Advanced Moisturizing Face Cream Exosome-based advanced moisturizing face cream for skin hydration, containing MSC-derived exosomes; sold through the online shop.

Quantifiable outcome

• 42% increase in saliva production documented in xerostomia treatment studies
• +3 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• Harvard Medical SchoolcoreStrategic or Co-development PartnerBioscience Institute Inc. operates at Harvard Medical School Life Lab in Boston, supporting research activities and advanced biomedical innovation within the U.S. market. This partnership provides access to cutting-edge research environment and academic collaboration opportunities.
• Università degli Studi di Roma Tor VergatacoreStrategic or Co-development PartnerBioscience Genomics facility located at the university in Rome, combining academic research capabilities with commercial molecular diagnostics operations. Enables collaboration in genomic research and access to academic expertise.
• Dubai Healthcare CitycoreStrategic or Co-development PartnerClinical facilities located within Dubai Healthcare City, the region's premier healthcare free zone. Provides regulatory framework and healthcare ecosystem for delivering regenerative medicine and longevity services in the Middle East.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Celltex Therapeutics: US-based company operating autologous MSC banking and MSC therapy clinics, closely comparable to Bioscience Institute's CELLSKILL and LIPOSKILL SAVE offerings.
• Cryo-Cell International: Public cord blood and cord tissue banking company — a direct comp to Bioscience Institute's cord blood SAVE and cord tissue SAVE services.
• ViaCord: Family cord blood banking service offering collection, processing, and cryopreservation of newborn stem cells — comparable to Bioscience Institute's stem cell banking offering.

Broad incumbents

• Mesoblast: Publicly listed MSC therapy developer with advanced clinical pipeline across inflammatory and degenerative indications — the formal pharma counterpart to Bioscience Institute's regenerative medicine portfolio.
• Natera: Large molecular diagnostics company offering non-invasive prenatal testing, carrier screening, and oncology liquid biopsy — overlapping directly with ULTRANIPT, MYCARRIER, and HELIXPAN.
• BrainStorm Cell Therapeutics: Clinical-stage cell therapy company developing autologous MSC therapies for neurodegenerative diseases — a more formalized competitor in MSC therapeutics.

Emerging players

• Pluristem Therapeutics: Clinical-stage cell therapy company developing placenta-derived MSC products, competing in the regenerative-medicine space with deeper regulatory engagement.
• Regeneus: Australian cell therapy company developing MSC and exosome-based treatments for pain and inflammatory conditions — adjacent regenerative-medicine competitor.
• Genomic Prediction: Genetic testing laboratory offering advanced reproductive and preimplantation screening — comparable to ULTRANIPT and MYCARRIER but with different commercial focus.

Regional players

• Cells4Life: UK-based cord blood and tissue stem cell bank — comparable banking services and indication breadth, but primarily serving UK/European families.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/bioinstitute
• YouTubeyoutube.com/@bioscienceinstitute
• Facebookfacebook.com/BioscienceInstitute
• LinkedInlinkedin.com/company/bioscience-institute-spa
• Instagraminstagram.com/bioscience.institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioscience Institute